<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib137">
 <label>137</label>
 <element-citation publication-type="book" id="sref137">
  <source>Immunomic Therapeutics. ITI Forms Collaboration with EpiVax &amp; PharmaJet to Develop Novel Vaccine Candidate against COVID-19 Using its Investigational UNITE Platform</source>
  <year>2020</year>
  <comment>[cited 2020 May 28]; Available from:</comment>
  <ext-link ext-link-type="uri" xlink:href="https://www.immunomix.com/immunomic-therapeutics-forms-collaboration-with-epivax-and-pharmajet-to-develop-novel-vaccine-candidate-against-covid-19-using-its-investigational-unite-platform/" id="intref0045" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.immunomix.com/immunomic-therapeutics-forms-collaboration-with-epivax-and-pharmajet-to-develop-novel-vaccine-candidate-against-covid-19-using-its-investigational-unite-platform/</ext-link>
 </element-citation>
</ref>
